Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT01719185

The Effect of Phentermine and B12 on Weight Loss Among Obese Patients

A Pilot Study to Assess Whether the Combination of Phentermine and B12 Has a Significant Effect on Weight Loss Among an Obese Study Population

Sponsor: Dr. Michael Lang

Conditions Hypertension Obesity

Interventions Phentermine Phentermine and B12

Updated 6 times since 2017 Last updated: Aug 11, 2015 Started: Sep 30, 2012 Primary completion: Jan 31, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01719185, this EARLY_PHASE1 trial focuses on Hypertension and Obesity and remains completed. Sponsored by Dr. Michael Lang, it has been updated 6 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed Phase 0

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dr. Michael Lang

Data source: East Carolina University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Greenville, United States